These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 17174865)
1. Comparison of paclitaxel-eluting stent and sirolimus-eluting stent expansion at incremental delivery pressures. Javaid A; Chu WW; Cheneau E; Clavijo LC; Satler LF; Kent KM; Weissman NJ; Pichard AD; Waksman R Cardiovasc Revasc Med; 2006; 7(4):208-11. PubMed ID: 17174865 [TBL] [Abstract][Full Text] [Related]
2. Underexpansion of sirolimus-eluting stents: incidence and relationship to delivery pressure. Cheneau E; Satler LF; Escolar E; Suddath WO; Kent KM; Weissman NJ; Waksman R; Pichard AD Catheter Cardiovasc Interv; 2005 Jun; 65(2):222-6. PubMed ID: 15900554 [TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study. Petronio AS; De Carlo M; Branchitta G; Papini B; Ciabatti N; Gistri R; Cortese B; Gherarducci G; Barsotti A J Am Coll Cardiol; 2007 Feb; 49(5):539-46. PubMed ID: 17276176 [TBL] [Abstract][Full Text] [Related]
4. Effect of intravascular ultrasound-guided adjuvant high-pressure non-compliant balloon post-dilation after drug-eluting stent implantation. Muraoka Y; Sonoda S; Tsuda Y; Tanaka S; Okazaki M; Otsuji Y Heart Vessels; 2011 Nov; 26(6):565-71. PubMed ID: 21181171 [TBL] [Abstract][Full Text] [Related]
5. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial. Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ JACC Cardiovasc Interv; 2011 Mar; 4(3):310-6. PubMed ID: 21435609 [TBL] [Abstract][Full Text] [Related]
6. Impact of a prolonged delivery inflation time for optimal drug-eluting stent expansion. Kawasaki T; Koga H; Serikawa T; Orita Y; Ikeda S; Mito T; Gotou Y; Shintani Y; Tanaka A; Tanaka H; Fukuyama T; Koga N Catheter Cardiovasc Interv; 2009 Feb; 73(2):205-11. PubMed ID: 19085915 [TBL] [Abstract][Full Text] [Related]
7. Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis. Iofina E; Haager PK; Radke PW; Langenberg R; Blindt R; Ortlepp J; Kühl H; Hanrath P; Hoffmann R Catheter Cardiovasc Interv; 2005 Jan; 64(1):28-34. PubMed ID: 15619307 [TBL] [Abstract][Full Text] [Related]
8. Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study. Futamatsu H; Sabaté M; Angiolillo DJ; Jimenez-Quevedo P; Corros C; Morikawa-Futamatsu K; Alfonso F; Jiang J; Cervinka P; Hernandez-Antolin R; Macaya C; Bass TA; Costa MA J Am Coll Cardiol; 2006 Sep; 48(6):1139-45. PubMed ID: 16978996 [TBL] [Abstract][Full Text] [Related]
9. Intravascular ultrasound assessment of drug-eluting stent expansion. de Ribamar Costa J; Mintz GS; Carlier SG; Fujii K; Sano K; Kimura M; Tanaka K; Costa RA; Lui J; Na Y; Castellanos C; Biro S; Moussa I; Stone GW; Moses JW; Leon MB Am Heart J; 2007 Feb; 153(2):297-303. PubMed ID: 17239693 [TBL] [Abstract][Full Text] [Related]
10. Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans. Suh JW; Park JS; Cho HJ; Kim MS; Kang HJ; Cho YS; Koo BK; Chung WY; Youn TJ; Chae IH; Choi DJ; Kim HS; Sohn DW; Oh BH; Park YB Int J Cardiol; 2007 Apr; 117(1):31-6. PubMed ID: 17292498 [TBL] [Abstract][Full Text] [Related]
11. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. Togni M; Eber S; Widmer J; Billinger M; Wenaweser P; Cook S; Vogel R; Seiler C; Eberli FR; Maier W; Corti R; Roffi M; Lüscher TF; Garachemani A; Hess OM; Wandel S; Meier B; Jüni P; Windecker S J Am Coll Cardiol; 2007 Sep; 50(12):1123-31. PubMed ID: 17868802 [TBL] [Abstract][Full Text] [Related]
12. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials. Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564 [TBL] [Abstract][Full Text] [Related]
13. Different edge effects of paclitaxel- and sirolimus-eluting stents on proximal and distal edges in patients with unstable angina: serial intravascular ultrasound analysis. Chen SL; Ye F; Zhang JJ; Liu ZZ; Shan SJ; Sun XW; Zhang AP; Chen JG; Xu YW; Yang S; Chen F; Luo WP Chin Med J (Engl); 2009 Jul; 122(14):1603-9. PubMed ID: 19719958 [TBL] [Abstract][Full Text] [Related]
14. "Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study". Cervinka P; Costa MA; Angiolillo DJ; Spacek R; Bystron M; Kvasnák M; Veselka J; Nanda H; Futamatsu H; Futamatsu K Catheter Cardiovasc Interv; 2006 Jun; 67(6):846-51. PubMed ID: 16683273 [TBL] [Abstract][Full Text] [Related]
15. Comparisons of the effects of stent eccentricity on the neointimal hyperplasia between sirolimus-eluting stent versus paclitaxel-eluting stent. Kim BK; Ko YG; Oh S; Kim JS; Kang WC; Jeon DW; Yang JY; Choi D; Hong MK; Ahn T; Jang Y Yonsei Med J; 2010 Nov; 51(6):823-31. PubMed ID: 20879046 [TBL] [Abstract][Full Text] [Related]
16. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Kim YH; Park SW; Lee SW; Park DW; Yun SC; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ; Circulation; 2006 Nov; 114(20):2148-53. PubMed ID: 17060388 [TBL] [Abstract][Full Text] [Related]
17. Intravascular ultrasound findings in patients with restenosis of sirolimus- and paclitaxel-eluting stents. Ohlmann P; Mintz GS; Kim SW; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R; Weissman NJ Int J Cardiol; 2008 Mar; 125(1):11-5. PubMed ID: 17442432 [TBL] [Abstract][Full Text] [Related]
18. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry). Hanna NN; Gaglia MA; Torguson R; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Maluenda G; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R Am J Cardiol; 2010 Aug; 106(4):504-10. PubMed ID: 20691308 [TBL] [Abstract][Full Text] [Related]
19. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries. Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW; JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464 [TBL] [Abstract][Full Text] [Related]
20. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents. Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J; J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]